PRKN and Parkinson disease: Such an explanation for the basis of disease variability in PD opens up new therapeutic strategies for Parkin-type ARJP by changing a severe disease phenotype into a milder form through redirecting PRKN pre-mRNA processing to induce an isoform missing exons 3 and 4.